↓ Skip to main content

Abdominopelvic FLASH Irradiation Improves PD-1 Immune Checkpoint Inhibition in Preclinical Models of Ovarian Cancer

Overview of attention for article published in Molecular Cancer Therapeutics, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter
19 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Abdominopelvic FLASH Irradiation Improves PD-1 Immune Checkpoint Inhibition in Preclinical Models of Ovarian Cancer
Published in
Molecular Cancer Therapeutics, December 2021
DOI 10.1158/1535-7163.mct-21-0358
Pubmed ID
Authors

Joshua T. Eggold, Stephanie Chow, Stavros Melemenidis, Jinghui Wang, Suchitra Natarajan, Phoebe E. Loo, Rakesh Manjappa, Vignesh Viswanathan, Elizabeth A. Kidd, Edgar Engleman, Oliver Dorigo, Billy W. Loo, Erinn B. Rankin

Twitter Demographics

The data shown below were collected from the profiles of 19 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 20%
Researcher 1 20%
Other 1 20%
Student > Doctoral Student 1 20%
Unknown 1 20%
Readers by discipline Count As %
Physics and Astronomy 2 40%
Immunology and Microbiology 1 20%
Unknown 2 40%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2022.
All research outputs
#1,845,201
of 20,710,163 outputs
Outputs from Molecular Cancer Therapeutics
#216
of 3,542 outputs
Outputs of similar age
#53,721
of 436,056 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#3
of 31 outputs
Altmetric has tracked 20,710,163 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,542 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,056 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.